Position in LLY
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$87,180,576
+$19,410,083 QoQ
Shares Held
72,685
-1.4% QoQ
Ownership
0.008%
of shares outstanding
% of Portfolio
0.23%
of 13F equity value
Holder Rank
#411
of 4,601 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026FIRST MANHATTAN CO. LLC. holds $503,568,677 across 13 Drug Manufacturers - General names. LLY ranks #3 (17.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
704,715 | $178,976,468 | |
| 2 | ABBV |
AbbVie Inc.
|
594,732 | $149,658,360 | |
| 3 | LLY |
ELI LILLY & Co
This page
|
72,685 | $87,180,576 | |
| 4 | AMGN |
Amgen Inc
|
87,079 | $31,533,047 | |
| 5 | MRK |
Merck & Co., Inc.
|
158,760 | $20,400,660 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
70,366 | $8,890,040 | |
| 7 | NVS |
Novartis AG
|
50,123 | $7,855,276 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
118,863 | $6,848,886 |
All Filings in LLY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $87,180,576 | 72,685 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $67,770,493 | 73,682 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $113,912,866 | 105,997 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $84,873,831 | 111,237 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $46,190,270 | 59,254 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $46,099,818 | 55,817 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $44,929,628 | 58,199 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $52,683,308 | 59,466 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $56,104,587 | 61,968 | Shares | Sole | 2024-08-15 | |
| 2024-03-31 | $41,591,297 | 53,462 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $34,153,865 | 58,591 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $31,417,807 | 58,492 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $28,506,949 | 60,785 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $28,957,174 | 84,320 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $32,219,528 | 88,070 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $39,173,205 | 121,148 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $42,684,879 | 131,650 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $37,724,951 | 131,735 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $34,945,144 | 126,512 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $24,928,908 | 107,894 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $24,813,636 | 108,111 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $20,758,691 | 111,116 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $17,618,454 | 104,350 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $15,602,048 | 105,405 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $17,246,452 | 105,046 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $14,618,868 | 105,384 | Shares | Sole | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||